Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 12, Issue 5
Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Commentary
Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors
Online download statistics by month:
Online download statistics by month: May 2024 to July 2025
Abstract
Full
Pdf
May 2024
664
669
253
Jun 2024
119
119
65
Jul 2024
84
85
39
Aug 2024
62
61
38
Sep 2024
77
77
42
Oct 2024
99
99
32
Nov 2024
152
154
48
Dec 2024
125
127
67
Jan 2025
69
77
34
Feb 2025
132
132
48
Mar 2025
83
84
40
Apr 2025
99
99
43
May 2025
90
90
52
Jun 2025
44
44
16
Jul 2025
1
1
0
Total
1900
1918
817
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF